Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Trading Update

12 Jan 2012 07:00

RNS Number : 4167V
Regenersis PLC
12 January 2012
 



 

12 January 2012

 

Regenersis plc

 

Trading Update

 

Regenersis plc (AIM:RGS) ("Regenersis" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, gives the following update on trading for the six months ended 31 December 2011.

 

The good start to the financial year, announced at the Annual General Meeting on 29 November 2011, has continued. The Group expects to report strong, double digit growth in both revenue and operating profit over the same period last year. This underpins the Board's confidence in the Group's ability to meet its expectations for the year. This positive view on future trading performance is despite the uncertain outlook for the European economy and the weakening of both the Euro and the Polish Zloty.

 

The largest increase in profitability has been seen in Western Europe, where the UK has responded strongly to the cost cutting and restructuring initiative carried out in 2011 and Germany has benefited from the signing of a significant new contract.

 

Group-wide growth has been driven by several significant new contracts gained over the last year in many of the geographies in which the Group operates, including identified growth markets such as South Africa and Turkey, as well as in the UK and Germany. These contracts have been secured with major international clients such as RIM, HTC, Nokia, Wincor Nixdorf and Intermec.

 

Regenersis is also pleased to confirm the signing of a significant contract with Virgin Media for the roll-out of our diagnostic In-Field Testers for set top boxes with their field force of service engineers. This contract is the conclusion of extensive development, by Regenersis, targeted at improving the customer experience for Virgin Media customers. The contract includes both the supply of the In-Field Testers and a licence agreement for their use.

 

Regenersis will report Interim Results for the six months ended 31 December 2011 on 13 March 2012.

 

Matthew Peacock, Executive Chairman of Regenersis, commented:

 

"We are pleased with progress and particularly pleased with the Virgin Media contract which is a global first in diagnostic technology for Set Top Boxes and further develops the technology base for our Advanced Solutions business."

 

 

Enquiries:

Regenersis plc

+44 (0) 1480 482866

Matthew Peacock / Jeremy Wilson

Arden Partners plc (Nomad and Joint Broker)

+44 (0) 121 423 8900

Steve Douglas / Justine Waldisberg

 

Panmure Gordon (UK) Limited (Joint Broker)

+44 (0) 20 7459 3600

Dominic Morley / Brett Jacobs

 

FTI Consulting

+44 (0) 20 7831 3113

Matt Dixon / Jon Snowball

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUBWGUPPGMG
Date   Source Headline
4th Oct 20185:41 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSFinal Results
27th Jul 20189:14 amRNSHolding(s) in Company
26th Jul 201811:00 amRNSDirector/PDMR Shareholding
11th Jul 20187:00 amRNSAppointment of Chief Financial Officer
11th Jul 20187:00 amRNSTrading Update and Notice of Results
29th Jun 20188:59 amRNSHolding(s) in Company
13th Jun 201812:16 pmRNSHolding(s) in Company
12th Jun 201812:28 pmRNSHolding(s) in Company
18th Apr 20182:40 pmRNSHolding(s) in Company
18th Apr 201812:05 pmRNSHolding(s) in Company
29th Mar 201811:40 amRNSDirector/PDMR Shareholding
28th Mar 20187:00 amRNSAppointment of Chief Executive Officer
26th Mar 201812:04 pmRNSHolding(s) in Company
22nd Mar 20182:27 pmRNSHolding(s) in Company
20th Mar 20187:11 amRNSHalf-year Report
9th Feb 201812:31 pmRNSDirector/PDMR Shareholding
19th Jan 201810:27 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSTrading Update and Notice of Results
19th Dec 20175:35 pmRNSResult of AGM
24th Nov 20172:48 pmRNSPosting of Annual Report & Notice of AGM
8th Nov 20172:05 pmRNSSecond Price Monitoring Extn
8th Nov 20172:00 pmRNSPrice Monitoring Extension
7th Nov 20177:00 amRNSFinal Results
6th Nov 201710:25 amRNSHolding(s) in Company
3rd Nov 20175:03 pmRNSNotice of Results
13th Oct 20171:01 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreparation of preliminary results
27th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 20175:54 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSBoard Update
4th Sep 20177:00 amRNSUpdates on revenue and management
3rd Aug 201712:37 pmRNSHolding(s) in Company
11th Jul 20173:33 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSTrading Statement
6th Jun 20173:16 pmRNSHolding(s) in Company
30th May 20177:00 amRNSDirectorate Change
16th May 20177:00 amRNSUpdate on Ordinary Shares
12th May 20173:53 pmRNSHolding(s) in Company
10th May 20173:34 pmRNSDirector/PDMR Shareholding
9th May 201712:27 pmRNSDirector/PDMR Shareholding
9th May 201712:26 pmRNSHolding(s) in Company
4th May 20177:00 amRNSResult of Placing
3rd May 20175:04 pmRNSProposed Placing
26th Apr 20176:01 pmRNSHolding(s) in Company
25th Apr 20177:00 amRNSQ3 Trading Update, Cash Flow Review and Funding
15th Mar 20172:55 pmRNSHolding(s) in Company
15th Mar 201711:27 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSDirector/PDMR Shareholding
14th Mar 20172:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.